Insider · CIK 0001682027

Dylan-Hyde Tyler

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001682027

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-16	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−1,110 sh	$28.24	−$31.3K	25,204
2018-01-16	CRSPCRISPR Therapeutics AGM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+1,110 sh	$12.57	+$14K	26,314
2018-01-16	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−45K sh	$28.00	−$1.26M	25,204
2018-01-16	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−19.9K sh	—	—	5,237
2018-01-16	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,110 sh	—	—	36,663
2018-01-16	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−19.9K sh	$28.10	−$559K	25,204
2018-01-16	CRSPCRISPR Therapeutics AGM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+19.9K sh	$12.57	+$250K	45,094
2018-01-02	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−8,000 sh	$25.75	−$206K	70,204
2018-01-02	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,490 sh	—	—	37,773
2018-01-02	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,510 sh	—	—	25,157
2018-01-02	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−30K sh	$20.55	−$617K	70,204
2018-01-02	CRSPCRISPR Therapeutics AGM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+8,000 sh	$12.57	+$101K	78,204
2017-12-29	CRSPCRISPR Therapeutics AGM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+6,230 sh	$14.43	+$89.9K	121,434
2017-12-29	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−15K sh	$22.68	−$340K	100,204
2017-12-29	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−8,000 sh	$23.76	−$190K	115,204
2017-12-29	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−1,070 sh	$21.75	−$23.3K	123,204
2017-12-29	CRSPCRISPR Therapeutics AGM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+9,070 sh	$12.57	+$114K	124,274
2017-12-29	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−6,230 sh	$21.75	−$136K	115,204
2017-12-29	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−9,070 sh	—	—	44,263
2017-12-29	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,230 sh	—	—	58,070
2017-12-28	CRSPCRISPR Therapeutics AGM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+700 sh	$14.43	+$10.1K	115,904
2017-12-28	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−700 sh	$21.75	−$15.2K	115,204
2017-12-28	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−700 sh	—	—	64,300
2017-12-22	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−15K sh	$20.55	−$308K	115,204
2017-12-15	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−15K sh	$18.90	−$283K	130,204
2017-08-08	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−1,313 sh	$18.60	−$24.4K	153,204
2017-08-07	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−13.2K sh	$18.56	−$245K	154,517
2017-08-04	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−477 sh	$18.55	−$8,848.35	167,727
2017-06-15	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+65K sh	—	—	65,000
2017-05-01	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−1,852 sh	$16.61	−$30.8K	168,204
2017-04-28	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−4,912 sh	$16.62	−$81.6K	170,056
2017-04-27	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−13.5K sh	$16.84	−$228K	174,968
2017-04-26	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−3,200 sh	$16.76	−$53.6K	180,495
2017-04-25	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−4,800 sh	$16.87	−$81K	183,695
2017-04-24	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−3,522 sh	$16.44	−$57.9K	188,495
2017-04-21	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−3,010 sh	$17.02	−$51.2K	192,017
2017-04-20	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−2,937 sh	$17.37	−$51K	195,027
2017-04-19	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−2,310 sh	$18.58	−$42.9K	197,964
2017-04-19	CRSPCRISPR Therapeutics AGS Sale	Chief Legal Officer	SSale	−4,930 sh	$17.49	−$86.2K	200,274

Recent filings

Accepted (ET)
Jan 184
Dylan-Hyde Tyler0000899243-18-001348
SEC(opens sec.gov)
Jan 44
Dylan-Hyde Tyler0000899243-18-000520
SEC(opens sec.gov)
Jan 24
Dylan-Hyde Tyler0000899243-18-000074
SEC(opens sec.gov)

Companies

CRISPR Therapeutics AGChief Legal OfficerCRSP

Address

C/O CRISPR THERAPEUTICS, INC. 200 SIDNEY ST.

CAMBRIDGE, MA, 02139